Gene · 7030
Papers3,398
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 3,398
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| PEComa-its clinical features, histopathology, and current therapy. | Jpn J Clin Oncol | 2025 | 40336169 | PubTator, text mining | PubMed |
| Comparative analysis of oncologic outcomes in surgically treated patients with renal cell carcinoma and renal vein thrombosis by pathologic subtypes. | Sci Rep | 2025 | 40335555 | PubTator, text mining | PubMed |
Clinically Sporadic Folliculin -mutated Renal Epithelial Neoplasms Represent a Mixture of True Somatic Folliculin -mutated and Occult Birt-Hogg-Dubé Syndrome-associated Cases : Morphologic and Molecular Overlap With TSC/MTOR -mutated Eosinophilic Renal Neoplasms and MiT Family Translocation Renal Cell Carcinoma. | Am J Surg Pathol | 2025 | 40321032 | PubTator, text mining | PubMed |
| Clinicopathological and molecular features of so-called low-grade oncocytic fumarate hydratase-deficient renal cell carcinoma: a study of 5 cases. | Virchows Arch | 2025 | 40304778 | PubTator, text mining | PubMed |
| A Lung Epithelioid Hemangioendothelioma Subtype with YAP1::TFE3 Fusion: A Case Report. | Int J Surg Pathol | 2025 | 40296692 | PubTator, text mining | PubMed |
| Renal Epithelioid Angiomyolipoma: Prognostic Implications of Targeted Immunohistochemical and Molecular Markers in Conjunction with Clinicopathologic Features. | Am J Surg Pathol | 2025 | 40289813 | PubTator, text mining | PubMed |
| D-mannose suppresses the angiogenesis and progression of colorectal cancer. | Acta Biochim Biophys Sin (Shanghai) | 2025 | 40259886 | PubTator, text mining | PubMed |
| SFPQ::TFE3-rearranged PEComa: Differences and analogies with renal cell carcinoma carrying the same translocation. | Pathol Res Pract | 2025 | 40239600 | PubTator, text mining | PubMed |
| TFE3 fusion oncoprotein condensates drive transcriptional reprogramming and cancer progression in translocation renal cell carcinoma. | Cell Rep | 2025 | 40222010 | PubTator, text mining | PubMed |
| Mechanistic insights into arimoclomol mediated effects on lysosomal function in Niemann-pick type C disease. | Mol Genet Metab | 2025 | 40215728 | PubTator, text mining | PubMed |
| TFEB and TFE3 regulate STING1-dependent immune responses by controlling type I interferon signaling. | Autophagy | 2025 | 40195022 | PubTator, text mining | PubMed |
| TFE3-rearranged ossifying fibromyxoid tumors are uniquely negative for glycoprotein non-metastatic melanoma protein B: A study of 13 TFE3-rearranged mesenchymal tumors. | Hum Pathol | 2025 | 40189028 | PubTator, text mining | PubMed |
| Examination of the histogenesis of epithelial cysts in angiomyolipoma with epithelial cysts (AMLEC) using GPNMB and TSC2 immunostains. | Hum Pathol | 2025 | 40180055 | PubTator, text mining | PubMed |
| A rare case of Alveolar Soft-Part Sarcoma in the Uterine cervix. | Diagn Pathol | 2025 | 40176092 | PubTator, text mining | PubMed |
| Eosinophilic solid and cystic renal cell carcinoma: A case with two novel TSC2 mutations. | Pathol Res Pract | 2025 | 40174278 | PubTator, text mining | PubMed |
| Lysine-arginine imbalance overcomes therapeutic tolerance governed by the transcription factor E3-lysosome axis in glioblastoma. | Nat Commun | 2025 | 40169552 | PubTator, text mining | PubMed |
| TFE3 fusions drive oxidative metabolism and ferroptosis resistance in translocation renal cell carcinoma. | EMBO Mol Med | 2025 | 40148585 | PubTator, text mining | PubMed |
| The Sequence [RRKLPVGRS] Is a Nuclear Localization Signal for Importin 8 Binding (NLS8): A Chemical Biology and Bioinformatics Study. | Int J Mol Sci | 2025 | 40141456 | PubTator, text mining | PubMed |
| The inducible role of autophagy in cell death: emerging evidence and future perspectives. | Cell Commun Signal | 2025 | 40140912 | PubTator, text mining | PubMed |
| Antagonistic roles for MITF and TFE3 in melanoma plasticity. | Cell Rep | 2025 | 40138313 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7030/papers?page=13